Zafer E. Ozturk

559 total citations
16 papers, 419 citations indexed

About

Zafer E. Ozturk is a scholar working on Dermatology, Physiology and Immunology and Allergy. According to data from OpenAlex, Zafer E. Ozturk has authored 16 papers receiving a total of 419 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Dermatology, 7 papers in Physiology and 7 papers in Immunology and Allergy. Recurrent topics in Zafer E. Ozturk's work include Dermatology and Skin Diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Asthma and respiratory diseases (6 papers). Zafer E. Ozturk is often cited by papers focused on Dermatology and Skin Diseases (8 papers), Allergic Rhinitis and Sensitization (6 papers) and Asthma and respiratory diseases (6 papers). Zafer E. Ozturk collaborates with scholars based in United States, Germany and Italy. Zafer E. Ozturk's co-authors include Gregory P. Geba, Richard A. Petruschke, Bernard R. Rubin, Sandra Navarra, Erluo Chen, John Londoño, Vedat Hamuryudan, Hasan Yazıcı, Veronica Piziak and Henry G. Bone and has published in prestigious journals such as Journal of the American Academy of Dermatology, British Journal of Dermatology and BMJ Open.

In The Last Decade

Zafer E. Ozturk

15 papers receiving 381 citations

Peers

Zafer E. Ozturk
Д. С. Новикова Russia
Susan Johnson United States
Kunihiko Wakaki Japan
F. Arellano Spain
Bernard R. Rubin United States
John Golding United Kingdom
Orsolya Tímár Hungary
İbrahim Halil Türkbeyler Türkiye
Lilia Andrade-Ortega Mexico
G. D. Kersley United Kingdom
Д. С. Новикова Russia
Zafer E. Ozturk
Citations per year, relative to Zafer E. Ozturk Zafer E. Ozturk (= 1×) peers Д. С. Новикова

Countries citing papers authored by Zafer E. Ozturk

Since Specialization
Citations

This map shows the geographic impact of Zafer E. Ozturk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zafer E. Ozturk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zafer E. Ozturk more than expected).

Fields of papers citing papers by Zafer E. Ozturk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zafer E. Ozturk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zafer E. Ozturk. The network helps show where Zafer E. Ozturk may publish in the future.

Co-authorship network of co-authors of Zafer E. Ozturk

This figure shows the co-authorship network connecting the top 25 collaborators of Zafer E. Ozturk. A scholar is included among the top collaborators of Zafer E. Ozturk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zafer E. Ozturk. Zafer E. Ozturk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Asbell, Penny A., Esen K. Akpek, Winston Chamberlain, et al.. (2025). Conjunctivitis in Adults with Atopic Dermatitis Treated with Dupilumab: An Observational Study of Clinical Characteristics, Symptomatology, and Treatment. Advances in Therapy. 42(7). 3285–3305. 1 indexed citations
2.
Paller, Amy S., Mercedes E. González, Judith Jaeger, et al.. (2024). Attentiveness and mental health in adolescents with moderate-to-severe atopic dermatitis without ADHD. Archives of Dermatological Research. 316(8). 497–497. 3 indexed citations
3.
Merola, Joseph F., Albert S. Chiou, Emmanuel During, et al.. (2024). Improved sleep parallels improvements in atopic dermatitis signs, symptoms, and quality of life in adult patients treated with dupilumab: 24-week results from the DUPISTAD study. Journal of the American Academy of Dermatology. 91(6). 1199–1201.
4.
Merola, Joseph F., Albert S. Chiou, Emmanuel During, et al.. (2023). Dupilumab significantly improves sleep in adults with atopic dermatitis: results from the 12-week placebo-controlled period of the 24-week phase IV randomized double-blinded placebo-controlled DUPISTAD study. British Journal of Dermatology. 189(6). 685–694. 13 indexed citations
5.
Calzavara‐Pinton, Piergiacomo, Jarmila Čelakovská, Hilde Lapeere, et al.. (2023). Baseline Demographics, Comorbidities, Treatment Patterns and Burden of Atopic Dermatitis in Adults and Adolescents from the GLOBOSTAD Long-Term Observational Study. Advances in Therapy. 40(12). 5366–5382. 3 indexed citations
6.
Beck, Lisa A., Diamant Thaçi, Mette Deleuran, et al.. (2021). Laboratory safety of dupilumab for up to 3 years in adults with moderate-to-severe atopic dermatitis: results from an open-label extension study. Journal of Dermatological Treatment. 33(3). 1608–1616. 16 indexed citations
7.
Bruin‐Weller, Marjolein de, Andrew Pink, Ana M. Giménez‐Arnau, et al.. (2021). Disease burden and treatment history among adults with atopic dermatitis receiving systemic therapy: baseline characteristics of participants on the EUROSTAD prospective observational study. Journal of Dermatological Treatment. 32(2). 164–173. 19 indexed citations
8.
Paller, Amy S., Emma Guttman‐Yassky, Alan D. Irvine, et al.. (2020). Protocol for a prospective, observational, longitudinal study in paediatric patients with moderate-to-severe atopic dermatitis (PEDISTAD): study objectives, design and methodology. BMJ Open. 10(3). e033507–e033507. 8 indexed citations
9.
Palmer, Jacqueline B., et al.. (2016). Treatment patterns and costs for anti-TNFα biologic therapy in patients with psoriatic arthritis. BMC Musculoskeletal Disorders. 17(1). 261–261. 31 indexed citations
10.
Tucci, Joseph, et al.. (2015). Effect of zoledronic acid on serum calcium in Paget’s disease patients after educational strategies to improve calcium and vitamin D supplementation. Therapeutic Advances in Endocrinology and Metabolism. 6(4). 155–162. 1 indexed citations
11.
Kötter, Ina, Vedat Hamuryudan, Zafer E. Ozturk, & Hasan Yazıcı. (2010). Interferon therapy in rheumatic diseases: state-of-the-art 2010. Current Opinion in Rheumatology. 22(3). 278–283. 29 indexed citations
12.
Furst, Daniel E., Hong Chang, Jeffrey D. Greenberg, et al.. (2009). Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry.. PubMed. 27(4). 560–6. 36 indexed citations
13.
14.
Zerbini, Cristiano A. F., Zafer E. Ozturk, Joachim Grifka, et al.. (2005). Efficacy of etoricoxib 60 mg/day and diclofenac 150 mg/day in reduction of pain and disability in patients with chronic low back pain: results of a 4‐week, multinational, randomized, double-blind study. Current Medical Research and Opinion. 21(12). 2037–2049. 43 indexed citations
15.
Rubin, Bernard R., Sandra Navarra, John Londoño, et al.. (2004). Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout: A randomized controlled trial. Arthritis & Rheumatism. 50(2). 598–606. 131 indexed citations
16.
Zacher, J., Daniel Feldman, Roberto Gerli, et al.. (2003). A comparison of the therapeutic efficacy and tolerability of etoricoxib and diclofenac in patients with osteoarthritis. Current Medical Research and Opinion. 19(8). 725–736. 52 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Д. С. Новикова Breakdown of academic impact, for papers by Susan Johnson Breakdown of academic impact, for papers by Kunihiko Wakaki Breakdown of academic impact, for papers by F. Arellano Breakdown of academic impact, for papers by Bernard R. Rubin Breakdown of academic impact, for papers by John Golding Breakdown of academic impact, for papers by Orsolya Tímár Breakdown of academic impact, for papers by İbrahim Halil Türkbeyler Breakdown of academic impact, for papers by Lilia Andrade-Ortega Breakdown of academic impact, for papers by G. D. Kersley
Rankless by CCL
2026